TODAY'S MARKET INTELLIGENCE
Hengrui Medicine Receives Drug Registration Approval, Issues Overseas Regulatory Announcement
English summary
Hengrui Medicine (01276.HK) issued an overseas regulatory announcement stating it received drug registration approval. This approval may enrich its product pipeline and positively impact future results; the specific drug name was not disclosed.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence